AMNNA SHEIKH: Open Payments
NPI 1932862943 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$880 in 41 payments from 16 companies in 2025. Trend: 2023 $284 · 2024 $538 · 2025 $880
Food & beverage: $880
| Company | Payments | Amount |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | 12 | $252 |
| Novo Nordisk Inc | 8 | $158 |
| Lilly USA, LLC | 3 | $68 |
| Tandem Diabetes Care, Inc. | 3 | $52 |
| SANOFI-AVENTIS U.S. LLC | 2 | $48 |
| ABBVIE INC. | 2 | $40 |
| Novartis Pharmaceuticals Corporation | 2 | $36 |
| Dexcom, Inc. | 1 | $35 |
| Amgen Inc. | 1 | $33 |
| KYOWA KIRIN, INC. | 1 | $30 |
Products named: RECORLEV, GVOKE HYPOPEN, Ozempic, t:slim X2 Insulin Pump with Control-IQ, TZIELD, Wegovy, SYNTHROID, Dexcom G6 Transmitter.
Industry payments across NY — which companies pay providers there.
